國立高雄大學圖資館 |

Language: English

Back

Planning and analyzing clinical tria...

Kieser, Meinhard.

Planning and analyzing clinical trials with composite endpoints

Record Type:	Electronic resources : Monograph/item
Title/Author:	Planning and analyzing clinical trials with composite endpointsby Geraldine Rauch, Svenja Schuler, Meinhard Kieser.
Author:	Rauch, Geraldine.
other author:	Schuler, Svenja.
Published:	Cham :Springer International Publishing :2017.
Description:	xvi, 255 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Clinical trialsStatistical methods.
Online resource:	http://dx.doi.org/10.1007/978-3-319-73770-6
ISBN:	9783319737706$q(electronic bk.)

Planning and analyzing clinical trials with composite endpoints
Rauch, Geraldine.

Planning and analyzing clinical trials with composite endpoints[electronic resource] /by Geraldine Rauch, Svenja Schuler, Meinhard Kieser. - Cham :Springer International Publishing :2017. - xvi, 255 p. :ill., digital ;24 cm. - Springer series in pharmaceutical statistics,2366-8695. - Springer series in pharmaceutical statistics..

Preface -- Contents -- Part I General Introduction to Composite Endpoints -- 1 Definition and Rationale -- 2 Challenges of Composite Endpoints -- 3 Guideline View - Recommendations and Requirements -- 4 Clinical Trial Examples -- Part II Confirmatory Test Problem for a Single (Composite) Endpoint -- 5 The Single-Stage Design -- 6 Group-Sequential and Adaptive Designs -- 7 Related Software Code -- Part III Confirmatory Multiple Test Problem -- 8 Correlation Between Test Statistics -- 9 The Single-Stage Design -- 10 Group-Sequential and Adaptive Designs -- 11 Related Software Code -- Part IV Confirmatory Test Problem for a Weighted Composite Endpoint -- 12 Weighted Binary Composite Endpoint -- Weighted Time-to-Event Composite Endpoint -- 14 OtherWeighted Effect Measures -- 15 Related Software Code -- Part V Descriptive and Confirmatory Evaluation of the Components -- 16 Descriptive Analysis of the Components -- 17 Supplementary Confirmatory Analyses of the Components -- 18 Related Software Code -- Part VI Illustrating Clinical Trial Examples -- 19 Clinical Trial Examples with Binary (Composite) Endpoints -- 20 Clinical Trial Examples with (Composite) Time-to-Event Endpoints.

This book addresses the most important aspects of how to plan and evaluate clinical trials with a composite primary endpoint to guarantee a clinically meaningful and valid interpretation of the results. Composite endpoints are often used as primary efficacy variables for clinical trials, particularly in the fields of oncology and cardiology. These endpoints combine several variables of interest within a single composite measure, and as a result, all variables that are of major clinical relevance can be considered in the primary analysis without the need to adjust for multiplicity. Moreover, composite endpoints are intended to increase the size of the expected effects thus making clinical trials more powerful. The book offers practical advice for statisticians and medical experts involved in the planning and analysis of clinical trials. For readers who are mainly interested in the application of the methods, all the approaches are illustrated with real-world clinical trial examples, and the software codes required for fast and easy implementation are provided. The book also discusses all the methods in the context of relevant guidelines related to the topic. To benefit most from the book, readers should be familiar with the principles of clinical trials and basic statistical methods.

ISBN: 9783319737706$q(electronic bk.)

Standard No.: 10.1007/978-3-319-73770-6doiSubjects--Topical Terms:

181899
Clinical trials
--Statistical methods.

LC Class. No.: R853.C55

Dewey Class. No.: 610.727

Planning and analyzing clinical trials with composite endpoints
LDR:03484nmm a2200301 a 4500 001 526109
003 DE-He213
005 20180523022233.0
006 m d
007 cr nn 008maaau
008 180928s2017 gw s 0 eng d
020 $a 9783319737706$q(electronic bk.)
020 $a 9783319737690$q(paper)
024 7 $a 10.1007/978-3-319-73770-6 $2 doi
035 $a 978-3-319-73770-6
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.C55
082 0 4 $a 610.727 $2 23
090 $a R853.C55 $b R241 2017
100 1 $a Rauch, Geraldine. $3 798768
245 1 0 $a Planning and analyzing clinical trials with composite endpoints $h [electronic resource] / $c by Geraldine Rauch, Svenja Schuler, Meinhard Kieser.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xvi, 255 p. : $b ill., digital ; $c 24 cm.
490 1 $a Springer series in pharmaceutical statistics, $x 2366-8695
505 0 $a Preface -- Contents -- Part I General Introduction to Composite Endpoints -- 1 Definition and Rationale -- 2 Challenges of Composite Endpoints -- 3 Guideline View - Recommendations and Requirements -- 4 Clinical Trial Examples -- Part II Confirmatory Test Problem for a Single (Composite) Endpoint -- 5 The Single-Stage Design -- 6 Group-Sequential and Adaptive Designs -- 7 Related Software Code -- Part III Confirmatory Multiple Test Problem -- 8 Correlation Between Test Statistics -- 9 The Single-Stage Design -- 10 Group-Sequential and Adaptive Designs -- 11 Related Software Code -- Part IV Confirmatory Test Problem for a Weighted Composite Endpoint -- 12 Weighted Binary Composite Endpoint -- Weighted Time-to-Event Composite Endpoint -- 14 OtherWeighted Effect Measures -- 15 Related Software Code -- Part V Descriptive and Confirmatory Evaluation of the Components -- 16 Descriptive Analysis of the Components -- 17 Supplementary Confirmatory Analyses of the Components -- 18 Related Software Code -- Part VI Illustrating Clinical Trial Examples -- 19 Clinical Trial Examples with Binary (Composite) Endpoints -- 20 Clinical Trial Examples with (Composite) Time-to-Event Endpoints.
520 $a This book addresses the most important aspects of how to plan and evaluate clinical trials with a composite primary endpoint to guarantee a clinically meaningful and valid interpretation of the results. Composite endpoints are often used as primary efficacy variables for clinical trials, particularly in the fields of oncology and cardiology. These endpoints combine several variables of interest within a single composite measure, and as a result, all variables that are of major clinical relevance can be considered in the primary analysis without the need to adjust for multiplicity. Moreover, composite endpoints are intended to increase the size of the expected effects thus making clinical trials more powerful. The book offers practical advice for statisticians and medical experts involved in the planning and analysis of clinical trials. For readers who are mainly interested in the application of the methods, all the approaches are illustrated with real-world clinical trial examples, and the software codes required for fast and easy implementation are provided. The book also discusses all the methods in the context of relevant guidelines related to the topic. To benefit most from the book, readers should be familiar with the principles of clinical trials and basic statistical methods.
650 0 $a Clinical trials $x Statistical methods. $3 181899
650 1 4 $a Statistics. $3 182057
650 2 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 274067
650 2 4 $a Biostatistics. $3 339693
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Schuler, Svenja. $3 798769
700 1 $a Kieser, Meinhard. $3 798770
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Springer series in pharmaceutical statistics. $3 753654
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-73770-6
950 $a Mathematics and Statistics (Springer-11649)